Lindbrook Capital, LLC Uro Gen Pharma Ltd. Transaction History
Lindbrook Capital, LLC
- $1.05 Billion
- Q1 2024
A detailed history of Lindbrook Capital, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 160 shares of URGN stock, worth $2,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160
Previous 62
158.06%
Holding current value
$2,540
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding URGN
# of Institutions
113Shares Held
24MCall Options Held
46.9KPut Options Held
44.3K-
Rtw Investments, LP New York, NY3.26MShares$51.7 Million0.78% of portfolio
-
Great Point Partners LLC Greenwich, CT2.62MShares$41.6 Million9.62% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$36.6 Million0.26% of portfolio
-
Black Rock Inc. New York, NY1.72MShares$27.3 Million0.0% of portfolio
-
Cowen And Company, LLC1.63MShares$25.8 Million0.82% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $361M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...